Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 May;37(5):517-23.
doi: 10.1007/s001250050141.

A non-invasive assessment of hepatic glycogen kinetics and post-absorptive gluconeogenesis in man

Affiliations

A non-invasive assessment of hepatic glycogen kinetics and post-absorptive gluconeogenesis in man

L J Gay et al. Diabetologia. 1994 May.

Abstract

A novel approach to the study of hepatic glycogen kinetics and fractional gluconeogenesis in vivo is described. Ten healthy female subjects were fed an iso-caloric diet containing 55% carbohydrate energy with a 13C abundance of 1.083 atom percent for a 3-day baseline period; then, a diet of similar composition, but providing carbohydrate with a 13C abundance of 1.093 atom percent was started and continued for 5 days. Resting respiratory gas exchanges, urinary nitrogen excretion, breath 13CO2 and plasma 13C glucose were measured every morning in the fasting state. The enrichment in 13C of hepatic glycogen was calculated from these measured data. 13C glycogen enrichment increased after switching to a 13C enriched carbohydrate diet, and was identical to the 13C enrichment of dietary carbohydrates after 3 days. The time required to renew 50% of hepatic glycogen, as determined from the kinetics of 13C glycogen enrichment, was 18.9 +/- 3.6 h. Fractional gluconeogenesis, as determined from the difference between the enrichments of glucose oxidized originating from hepatic glycogen and plasma glucose 13C was 50.8 +/- 5.3%. This non-invasive method will allow the study of hepatic glycogen metabolism in insulin-resistant patients.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Baillieres Clin Endocrinol Metab. 1987 Nov;1(4):911-35 - PubMed
    1. J Clin Invest. 1988 May;81(5):1563-71 - PubMed
    1. Fed Proc. 1982 Jan;41(1):104-9 - PubMed
    1. Clin Chim Acta. 1964 Nov;10:481-3 - PubMed
    1. Am J Clin Nutr. 1988 Apr;47(4):608-28 - PubMed

Publication types

LinkOut - more resources